F3 and early-onset autosomal dominant Alzheimer disease: Due to the inflammatory nature of Alzheimer's disease, it seems that estrogen levels and increasing the duration of estrogen use may affect the process of Alzheimer's disease through neurotrophic, anti-inflammatory effects, increasing cerebral blood flow and reducing the formation of f3-amyloid and increasing the expression of apolipoprotein E gene.